|Cancer||gastric cancer,non-small-cell lung cancer,pancreatic cancer,|
LncRNA HMlincRNA717 is significantly down-regulated in gastric cell lines (1), non-small cell lung cancer (NSCLC) tissues and cell lines (2) and pancreatic cancer (3). HMlincRNA717 level is associated with clinicopathological parameter in gastric and lung cancer (1, 2, 3) and is an independent prognostic factor for lung and pancreatic cancer patients (2, 3).
. Shao Y, Chen H, Jiang X, Chen S, Li P, et al. (2014). Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol 35(10): 9591-5. link pubmed
. Xie X, Liu HT, Mei J, Ding FB, Xiao HB, et al. (2014). LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis. Int J Clin Exp Pathol 7(12): 8881-6. link pubmed
. Sun XL, Cao GH, Cao Y, Jiang X, Li XK, et al. (2016). Association of LncRNA HMlincRNA717 with prognosis in pancreatic cancer. Eur Rev Med Pharmacol Sci 20(11): 2230-4. link pubmed